Tanke Biosciences Stock Shares Owned By Institutions
| TNBI Stock | USD 0.02 0.01 33.33% |
Tanke Biosciences fundamentals help investors to digest information that contributes to Tanke Biosciences' financial success or failures. It also enables traders to predict the movement of Tanke Pink Sheet. The fundamental analysis module provides a way to measure Tanke Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tanke Biosciences pink sheet.
Tanke |
Tanke Biosciences Company Shares Owned By Institutions Analysis
Tanke Biosciences' Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 0.0% of Tanke Biosciences are shares owned by institutions. This is 100.0% lower than that of the Financial Services sector and about the same as Shell Companies (which currently averages 0.0) industry. The shares owned by institutions for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Tanke Fundamentals
| Return On Equity | -0.1 | |||
| Return On Asset | -0.0012 | |||
| Profit Margin | (0.07) % | |||
| Operating Margin | (0) % | |||
| Current Valuation | 4.56 M | |||
| Shares Outstanding | 13.32 M | |||
| Price To Earning | (0.08) X | |||
| Price To Book | 0.02 X | |||
| Price To Sales | 0.09 X | |||
| Revenue | 28.56 M | |||
| Gross Profit | 9.94 M | |||
| EBITDA | 804.29 K | |||
| Net Income | (210.25 K) | |||
| Cash And Equivalents | 5.09 M | |||
| Cash Per Share | 0.38 X | |||
| Debt To Equity | 0.60 % | |||
| Current Ratio | 1.61 X | |||
| Book Value Per Share | 1.17 X | |||
| Cash Flow From Operations | (1.18 M) | |||
| Earnings Per Share | (0.12) X | |||
| Number Of Employees | 130 | |||
| Beta | 0.96 | |||
| Market Capitalization | 2 M | |||
| Total Asset | 28.85 M | |||
| Retained Earnings | 1.62 M | |||
| Working Capital | 7.46 M | |||
| Current Asset | 19.7 M | |||
| Current Liabilities | 12.23 M | |||
| Net Asset | 28.85 M |
About Tanke Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tanke Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tanke Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tanke Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Tanke Pink Sheet
Tanke Biosciences financial ratios help investors to determine whether Tanke Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tanke with respect to the benefits of owning Tanke Biosciences security.